Kayser S, Sanber K, Marconi G, Mattei A, Luskin MR, Kelkar A, Cerrano M, Kristensen DT, Roug AS, Sartor C, Giglio F, Riva M, Rizzo L, Saraceni F, Guerzoni S, Lessi F, Borlenghi E, Levis MJ, Schlenk RF, Jain T, Papayannidis C. Outcome of adult acute myeloid leukemia patients with extramedullary disease and treatment with venetoclax/hypomethylating agents. haematol [Internet]. 2025Feb.1 [cited 2025Jul.14];110(2):378-84. Available from: https://haematologica.org/article/view/haematol.2024.285985